OVERVIEW

Emerging Treatment and Management Paradigms In SpA is organized by Cleveland Clinic Center for Continuing Education and will be held from Aug 23, 2017 - Aug 23, 2019.

Target Audience:
The online series is designed for rheumatologists, allergists/immunologists, dermatologists, internal medicine physicians, and associated allied health practitioners, including nurse practitioners, nurses, and physician assistants interested in or using biologic therapeutics for autoimmune and inflammatory disorders. This CME Conference has been approved for a maximum of 0.50 AMA PRA Category 1 Credits.

Description:
Biologic Therapies VII: Precision Medicine in the Biologic Era online series brings together world leaders in immune-based therapies and addresses cutting-edge translational immunology and the latest data on biologic therapeutics.

This webcast will review the latest treatment approaches for SpA and the most up-to-date treatment recommendations for axial spondyloarthritis.

Learning Objectives:
• Discuss published treatment recommendations for axial spondyloarthritis.
• Review the evidence for the efficacy of current and emerging treatments for axial spondyloarthritis.
• Describe the regulatory path for approval of medications for non-radiographic axial spondyloarthritis (nrAxSpA).

Additional details will be posted as soon as they are available.